EVT 302 + Placebo + EVT 302 plus open label Nicotine replacement + Placebo plus open label Nicotine Replacement
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Aug 1, 2008 → May 1, 2009
NCT ID
NCT00738595About EVT 302 + Placebo + EVT 302 plus open label Nicotine replacement + Placebo plus open label Nicotine Replacement
EVT 302 + Placebo + EVT 302 plus open label Nicotine replacement + Placebo plus open label Nicotine Replacement is a phase 2 stage product being developed by Evotec for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00738595. Target conditions include Smoking Cessation.
What happened to similar drugs?
17 of 20 similar drugs in Smoking Cessation were approved
Approved (17) Terminated (0) Active (3)
Hype Score Breakdown
Clinical
12
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00738595 | Phase 2 | Completed |
Competing Products
20 competing products in Smoking Cessation